Vollständiger Abstract
Worum geht es in dieser Arbeit?
Cancer progression is shaped not only by genetic alterations but also by dynamic remodeling of regulated cell death. MicroRNAs (miRNAs) have emerged as central regulators of these processes by coordinating gene expression, metabolic balance, and stress responses. This review summarizes current understanding of how miRNAs modulate ferroptosis, anoikis, and pyroptosis across liver, lung, gastric, breast, and other cancers. They influence ferroptosis through lipid peroxidation and antioxidant systems, regulate anoikis via integrin signaling and cytoskeletal remodeling, and tune pyroptosis through inflammasome activation and gasdermin-mediated pore formation. Emerging evidence suggests that miRNAs function as integrative nodes linking metabolic reprogramming, immune-inflammatory signaling, and adaptive survival pathways. Their stability, druggability, and cross-pathway influence highlight their promise as biomarkers and therapeutic targets, and advancing RNA-based technologies may enable more precise manipulation of cell-death programs to overcome resistance and refine cancer treatment.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Di Xiao, Yanzhou Luo, Liyuan Liu, Yajie Lu, Xiaofang Xie, Zhaokai Zhou, Bin Ma, Fu Peng
- Quelle
- Frontiers in Pharmacology
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 1663-9812
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Di Xiao, Yanzhou Luo, Liyuan Liu, Yajie Lu, Xiaofang Xie, Zhaokai Zhou, Bin Ma, Fu Peng (2026). MircoRNAs as regulators of regulated cell death in cancer progression: a focus on ferroptosis, anoikis and pyroptosis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1862213
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1